Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

May 13, 2024

Study Completion Date

May 13, 2024

Conditions
Severe Asthma
Trial Locations (10)

1200

Research Site, Brussels

2650

Research Site, Edegem

2800

Research Site, Mechelen

3000

Research Site, Leuven

4000

Research Site, Liège

5101

Research Site, Erpent

6042

Research Site, Charleroi

7100

Research Site, La Louvière

8500

Research Site, Kortrijk

8800

Research Site, Roeselare

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY